TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+13.44%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$952M
AUM Growth
+$952M
(+6%)
Cap. Flow
-$50.6M
Cap. Flow
% of AUM
-5.31%
Top 10 Holdings %
Top 10 Hldgs %
58.55%
Holding
72
New
9
Increased
10
Reduced
8
Closed
15
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$19.2M |
| 2 |
iShares Biotechnology ETF
IBB
|
$11.8M |
| 3 |
PCYC
PHARMACYCLICS INC
PCYC
|
$10.4M |
| 4 |
Incyte
INCY
|
$8.46M |
| 5 |
CTRX
CATAMARAN CORP COM STK (CDA)
CTRX
|
$6.93M |
Top Sells
| 1 |
Puma Biotechnology
PBYI
|
$28.3M |
| 2 |
WCRX
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
|
$16.3M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
$15.5M |
| 4 |
Merck
MRK
|
$14.1M |
| 5 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
$9.42M |
Sector Composition
| 1 | Healthcare | 86.08% |
| 2 | Financials | 1.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Gilead Sciences
GILD
$140B
| $113M | 11.87% | 1,504,712 | – | – |
|
|
CELG
2
DELISTED
Celgene Corp
CELG
| $86.2M | 9.05% | 510,046 | – | – |
|
3
Regeneron Pharmaceuticals
REGN
$61.5B
| $71.8M | 7.53% | 260,699 | – | – |
|
4
Biogen
BIIB
$19.4B
| $53.7M | 5.64% | 191,983 | – | – |
|
|
ALXN
5
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $49.4M | 5.19% | 371,329 | – | – |
|
6
Amgen
AMGN
$155B
| $47.1M | 4.94% | 412,143 | – | – |
|
7
Vertex Pharmaceuticals
VRTX
$100B
| $37.1M | 3.9% | 499,764 | – | – |
|
|
AGN
8
DELISTED
Allergan plc
AGN
| $34.6M | 3.63% | 205,707 +114,207 | +125% | +$19.2M |
|
9
Perrigo
PRGO
$3.27B
| $33.9M | 3.56% | 221,124 +18,517 | +9% | +$2.84M |
|
|
10
iShares Biotechnology ETF
IBB
$5.6B
| $30.9M | 3.24% | 136,106 +52,166 | +62% | +$11.8M |
|
|
11
Incyte
INCY
$16.5B
| $29.8M | 3.13% | 588,300 +167,000 | +40% | +$8.46M |
|
|
AKRX
12
DELISTED
Akorn, Inc.
AKRX
| $23M | 2.42% | 935,758 | – | – |
|
|
SHPG
13
DELISTED
Shire pic
SHPG
| $21.8M | 2.29% | 154,153 | – | – |
|
14
Viatris
VTRS
$12.3B
| $21.2M | 2.22% | 488,209 | – | – |
|
|
15
Puma Biotechnology
PBYI
$254M
| $19.2M | 2.02% | 185,820 -272,996 | -60% | -$28.3M |
|
|
AGN
16
DELISTED
ALLERGAN INC
AGN
| $18.5M | 1.94% | 166,577 | – | – |
|
17
BioMarin Pharmaceuticals
BMRN
$11.2B
| $18.1M | 1.91% | 258,241 +76,371 | +42% | +$5.37M |
|
|
AET
18
DELISTED
Aetna Inc
AET
| $16.9M | 1.78% | 246,841 | – | – |
|
|
CBST
19
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $15.6M | 1.64% | 226,772 | – | – |
|
|
ALR
20
DELISTED
Alere Inc
ALR
| $13.4M | 1.4% | 369,553 | – | – |
|
21
Teva Pharmaceuticals
TEVA
$21.1B
| $12.5M | 1.31% | 311,476 -43,000 | -12% | -$1.72M |
|
22
Verastem
VSTM
$569M
| $11.6M | 1.22% | 1,018,827 +133,907 | +15% | +$1.53M |
|
23
Illumina
ILMN
$15.8B
| $11.5M | 1.21% | 103,841 | – | – |
|
|
PCYC
24
DELISTED
PHARMACYCLICS INC
PCYC
| $10.4M | 1.09% | +98,000 | New | +$10.4M |
|
25
Hologic
HOLX
$14.9B
| $9.94M | 1.04% | 444,687 -148,228 | -25% | -$3.31M |
|